Is Nitrous Oxide (whippets, Galaxy Gas) Legal in Alaska? (2026)

Instrument

AS 11.71.150 (Schedule IIA, hallucinogenic substances)

Source

https://www.akleg.gov/basis/statutes.asp#11.71.150

Retrieved

2026-10-08

Fingerprint

04c9a34ecca1186a

Sec. 11.71.150. Schedule IIA.  (a) A substance shall be placed in schedule IIA if it is found under AS 11.71.120 (c) to have a degree of danger or probable danger to a person or the public which is less than substances listed in schedule IA, but higher than substances listed in schedule IIIA.  (b) Schedule IIA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, whether optical, position, or geometric, or salts of isomers whenever the existence of these salts, isomers, or salts of isomers is possible within the specific chemical designation:        (1) 4-bromo-2, 5-dimethoxy-amphetamine, also known as 4-bromo-2, 5-dimethoxy-a-methylphenethylamine and 4-bromo-2, DMA;  (2) 2,5-dimethoxyamphetamine, also known as 2,5-dimethoxy-a-methylphenethylamine and 2,5-DMA;  (3) 4-methoxyamphetamine, also known as 4-methoxy-a-methylphenethylamine and paramethoxyamphetamine, PMA;  (4) 5-methoxy-3,4-methylenedioxy-amphetamine;  (5) 4-methyl-2,5-dimethoxy-amphetamine, also known as 4-methyl-2,5-dimethoxy-a-methylphenethylamine;  (6) 3,4-methylenedioxy amphetamine;  (7) 3,4,5-trimethoxy amphetamine;  (8) bufotenine, also known as 3-(B-dimethylaminoethyl)-5-hydroxyindole, 3-(2-dimethylaminoethyl)-5-indolol, N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine, and mappine;  (9) diethyltryptamine, also known as N, N-diethyltryptamine and DET;  (10) dimethyltryptamine, also known as DMT;  (11) ibogaine, also known as 7-ethyl-6, 6B, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido [1´,2´: 1, 2] azepino [5, 4-b] indole and tabernanthe iboga;  (12) lysergic acid diethylamide, also known as LSD;  (13) mescaline;  (14) n-ethyl-3-piperidyl benzilate;  (15) n-methyl-3-piperidyl benzilate;  (16) peyote;  (17) analogs of phencyclidine (PCP), including:             (A) ethylamine analog, also known by some trade or other names as follows: N-ethyl-1-phenylcyclohexylamine (1-phenylcyclohexyl)-ethylamine, N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;  (B) pyrrolidine analog, also known by some trade or other names as follows: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPY, PHP;  (C) thiophene analog, also known as 1-[1-(2-thienyl) cyclohexyl]piperidine and 2-thienylanalog of phencyclidine, TPCP, and TCP;  (D) 1-[1-(2-thienyl)-cyclohexyl]-pyrrolidine, also known as TCPy;  (18) psilocybin;  (19) psilocyn;  (20) 3,4-methylenedioxymethamphetamine (MDMA).  (c) Schedule IIA includes cocaine or coca leaves, and any salt, compound, derivative, mixture, isomer, ester, ether, or preparation of cocaine or coca leaves produced directly or indirectly by extraction from coca leaves, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, including the isomers, salts, and salts of isomers of cocaine and other derivatives of coca leaves whenever the existence of these esters, ethers, isomers or salts is possible, but does not include decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine.  (d) Schedule IIA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:        (1) amobarbital;  (2) mandrix or mandrax;  (3) mecloqualone;  (4) methaqualone;  (5) pentobarbital;  (6) phencyclidine, also known as PCP;  (7) secobarbital.  (e) Schedule IIA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the nervous system:        (1) amphetamine, its salts, optical isomers, and salts of its optical isomers;  (2) methamphetamine, its salts, isomers, and salts of its isomers;  (3) methylphenidate;  (4) phenmetrazine and its salts;  (5) fenethylline;  (6) N-ethylamphetamine;  (7) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, and MDEA;  (8) N-hydroxy-3,4-methylenedioxyamphetamine, also known as N-hydroxy-alpha-methyl-3,4-(methylenedioxy)phenethylamine, and N-hydroxy MDA;  (9) 4-methylaminorex, also known as 2-amino-4-methyl-5-phenyl-2-oxazoline;  (10) N,N-dimethylamphetamine, also known as N,N,alpha-trimethylybenzencethaneamine or N,N,alpha-trimethylphenethyline, its salts, optical isomers, and salts of optical isomers;  (11) cathinone;  (12) 2-methylamino-1-phenylpropan-1-one, also known as methcathinone and cat, its salts, optical isomers, and salts of isomers;  (13) 4-methylmethcathinone, also known as mephedrone, its salts, isomers, and salts of isomers;  (14) 3,4-methylenedioxypyrovalerone, also known as MDPV, its salts, isomers, and salts of isomers;  (15) substituted cathinones, including any compound, except bupropion or a compound listed in another schedule, structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:             (A) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;  (B) by substitution at the 3-position with an alkyl substituent;  (C) by substitution at the nitrogen atom with alkyl or dialkyl groups or by inclusion of the nitrogen atom in a cyclic structure.  (f) Schedule IIA includes, unless specifically excepted or unless listed in another schedule, any material, mixture, or preparation which contains any quantity of the following substances:        (1) immediate precursor to amphetamine and methamphetamine: phenylacetone also known as phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;  (2) immediate precursors to phencyclidine, also known as PCP:             (A) 1-phencylclohexylamine;  (B) 1-piperidinocyclohexanecarbonitrile, also known as PCC.

Instrument

Schedule IIA; Definitions

Source

https://www.akleg.gov/basis/statutes.asp?media=print&secStart=11.71.010&secEnd=11.71.900

Retrieved

2026-10-29

Fingerprint

7cb9739a84d3ab33

Sec. 11.71.150.   Schedule IIA.
 (a) A substance shall be placed in schedule IIA if it is found under
AS 11.71.120
(c) to have a degree of danger or probable danger to a person or the public which is less than substances listed in schedule IA, but higher than substances listed in schedule IIIA.
 (b) Schedule IIA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, whether optical, position, or geometric, or salts of isomers whenever the existence of these salts, isomers, or salts of isomers is possible within the specific chemical designation:
       (1) 4-bromo-2, 5-dimethoxy-amphetamine, also known as 4-bromo-2, 5-dimethoxy-a-methylphenethylamine and 4-bromo-2, DMA;
 (2) 2,5-dimethoxyamphetamine, also known as 2,5-dimethoxy-a-methylphenethylamine and 2,5-DMA;
 (3) 4-methoxyamphetamine, also known as 4-methoxy-a-methylphenethylamine and paramethoxyamphetamine, PMA;
 (4) 5-methoxy-3,4-methylenedioxy-amphetamine;
 (5) 4-methyl-2,5-dimethoxy-amphetamine, also known as 4-methyl-2,5-dimethoxy-a-methylphenethylamine;
 (6) 3,4-methylenedioxy amphetamine;
 (7) 3,4,5-trimethoxy amphetamine;
 (8) bufotenine, also known as 3-(B-dimethylaminoethyl)-5-hydroxyindole, 3-(2-dimethylaminoethyl)-5-indolol, N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine, and mappine;
 (9) diethyltryptamine, also known as N, N-diethyltryptamine and DET;
 (10) dimethyltryptamine, also known as DMT;
 (11) ibogaine, also known as 7-ethyl-6, 6B, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido [1´,2´: 1, 2] azepino [5, 4-b] indole and tabernanthe iboga;
 (12) lysergic acid diethylamide, also known as LSD;
 (13) mescaline;
 (14) n-ethyl-3-piperidyl benzilate;
 (15) n-methyl-3-piperidyl benzilate;
 (16) peyote;
 (17) analogs of phencyclidine (PCP), including:
            (A) ethylamine analog, also known by some trade or other names as follows: N-ethyl-1-phenylcyclohexylamine (1-phenylcyclohexyl)-ethylamine, N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
 (B) pyrrolidine analog, also known by some trade or other names as follows: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPY, PHP;
 (C) thiophene analog, also known as 1-[1-(2-thienyl) cyclohexyl]piperidine and 2-thienylanalog of phencyclidine, TPCP, and TCP;
 (D) 1-[1-(2-thienyl)-cyclohexyl]-pyrrolidine, also known as TCPy;
 (18) psilocybin;
 (19) psilocyn;
 (20) 3,4-methylenedioxymethamphetamine (MDMA).
 (c) Schedule IIA includes cocaine or coca leaves, and any salt, compound, derivative, mixture, isomer, ester, ether, or preparation of cocaine or coca leaves produced directly or indirectly by extraction from coca leaves, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, including the isomers, salts, and salts of isomers of cocaine and other derivatives of coca leaves whenever the existence of these esters, ethers, isomers or salts is possible, but does not include decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine.
 (d) Schedule IIA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
       (1) amobarbital;
 (2) mandrix or mandrax;
 (3) mecloqualone;
 (4) methaqualone;
 (5) pentobarbital;
 (6) phencyclidine, also known as PCP;
 (7) secobarbital.
 (e) Schedule IIA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the nervous system:
       (1) amphetamine, its salts, optical isomers, and salts of its optical isomers;
 (2) methamphetamine, its salts, isomers, and salts of its isomers;
 (3) methylphenidate;
 (4) phenmetrazine and its salts;
 (5) fenethylline;
 (6) N-ethylamphetamine;
 (7) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, and MDEA;
 (8) N-hydroxy-3,4-methylenedioxyamphetamine, also known as N-hydroxy-alpha-methyl-3,4-(methylenedioxy)phenethylamine, and N-hydroxy MDA;
 (9) 4-methylaminorex, also known as 2-amino-4-methyl-5-phenyl-2-oxazoline;
 (10) N,N-dimethylamphetamine, also known as N,N,alpha-trimethylybenzencethaneamine or N,N,alpha-trimethylphenethyline, its salts, optical isomers, and salts of optical isomers;
 (11) cathinone;
 (12) 2-methylamino-1-phenylpropan-1-one, also known as methcathinone and cat, its salts, optical isomers, and salts of isomers;
 (13) 4-methylmethcathinone, also known as mephedrone, its salts, isomers, and salts of isomers;
 (14) 3,4-methylenedioxypyrovalerone, also known as MDPV, its salts, isomers, and salts of isomers;
 (15) substituted cathinones, including any compound, except bupropion or a compound listed in another schedule, structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:
            (A) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
 (B) by substitution at the 3-position with an alkyl substituent;
 (C) by substitution at the nitrogen atom with alkyl or dialkyl groups or by inclusion of the nitrogen atom in a cyclic structure.
 (f) Schedule IIA includes, unless specifically excepted or unless listed in another schedule, any material, mixture, or preparation which contains any quantity of the following substances:
       (1) immediate precursor to amphetamine and methamphetamine: phenylacetone also known as phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;
 (2) immediate precursors to phencyclidine, also known as PCP:
            (A) 1-phencylclohexylamine;
 (B) 1-piperidinocyclohexanecarbonitrile, also known as PCC.

Sec. 11.71.900.   Definitions.
In this chapter, unless the context clearly requires otherwise,
       (1) "administer" means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means into the body of a patient or research subject by
            (A) a practitioner or, in the practitioner’s presence, by the practitioner’s authorized agent; or
 (B) the patient or research subject at the direction and in the presence of a practitioner;
 (2) “agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser, but does not include a common or contract carrier, public warehouseman, or employee of the carrier or warehouseman;
 (3) “cannabidiol oil” means the viscous liquid concentrate of cannabidiol extracted from the plant (genus) Cannabis containing not more than 0.3 percent delta-9-tetrahydrocannabinol;
 (4) "committee" means the Controlled Substances Advisory Committee established in
AS 11.71.100
;
 (5) “controlled substance” means a drug, substance, or immediate precursor included in the schedules set out in
AS 11.71.140
 — 11.71.190 or included in those schedules by an emergency regulation adopted under
AS 11.71.125
;
 (6) “counterfeit substance” means a controlled substance which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, number, or device of a manufacturer, distributor, or dispenser other than the person or persons who in fact manufactured, distributed, or dispensed the substance and which falsely purports or is represented to be the product of, or to have been distributed by, the other manufacturer, distributor, or dispenser;
 (7) "deliver" or “delivery” means the actual, constructive, or attempted transfer from one person to another of a controlled substance whether or not there is an agency relationship;
 (8) “dispense” means to deliver a controlled substance to an ultimate user or research subject by or under the lawful order of a practitioner, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery; “dispenser” means a practitioner who dispenses;
 (9) "distribute" means to deliver other than by administering or dispensing a controlled substance, whether or not there is any money or other item of value exchanged; it includes sale, gift, or exchange; “distributor” means a person who distributes;
 (10) "drug"
            (A) means
                 (i) a substance recognized as a drug in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to these publications;
 (ii) a substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals;
 (iii) a substance, other than food, intended to affect the structure or any function of the body of humans or animals; and
 (iv) a substance intended for use as a component of any article specified in (i), (ii), or (iii) of this subparagraph;
 (B) does not include a device or its components, parts, or accessories;
 (11) "hashish" means the dried, compressed, resinous product of the plant (genus) Cannabis;
 (12) "hashish oil" means the viscous liquid concentrate of tetrahydrocannabinols extracted from the plant (genus) Cannabis, but does not include cannabidiol oil;
 (13) “immediate precursor” means a substance which is by statute or regulation designated as the principal compound commonly used or produced primarily for use, and which is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance, the control of which is necessary to prevent, curtail, or limit manufacture of that controlled substance;
 (14) “manufacture”
            (A) means the production, preparation, propagation, compounding, conversion, growing, or processing of a controlled substance, either directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis; however, the growing of marijuana for personal use is not manufacturing;
 (B) includes the preparation, compounding, packaging, repackaging, labeling, or relabeling of a controlled substance or its container unless done in conformity with applicable federal law
                 (i) by a practitioner as an incident to the practitioner’s administering or dispensing of a controlled substance in the course of the practitioner’s professional practice; or
 (ii) by a practitioner, or by the practitioner’s authorized agent under the practitioner’s supervision, for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale;
 (15) "marijuana" means the seeds, and leaves, buds, and flowers of the plant (genus) Cannabis, whether growing or not; it does not include the resin or oil extracted from any part of the plants, or any compound, manufacture, salt, derivative, mixture, or preparation from the resin or oil, including hashish, hashish oil, and natural or synthetic tetrahydrocannabinol; it does not include the stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the stalks, fiber, oil or cake, or the sterilized seed of the plant that is incapable of germination; it does not include industrial hemp as defined in
AS 03.05.100
;
 (16) “opiate” means
            (A) a substance having an addiction-forming or addiction-sustaining capability similar to morphine or being capable of conversion into a drug having addiction-forming or addiction-sustaining capability; and
 (B) includes its racemic and levorotatory forms; but
 (C) does not include the dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan);
 (17) “opium poppy” means the plant of any species of Papaver containing the phenanthrine alkaloids of opium, except its seeds;
 (18) “peyote” means any part of the plant classified botanically as Lophophora Williamsii Lemaire, whether growing or not, the seeds of the plant, any extract from any part of the plant, and a compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or extracts, including mescaline;
 (19) “poppy straw” means all parts, except the seeds, of the opium poppy, after mowing;
 (20) “practitioner” means
            (A) a physician, dentist, advanced practice registered nurse, optometrist, veterinarian, scientific investigator, or other person licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to, or to administer or use in teaching or chemical analysis a controlled substance in the course of professional practice or research in the state;
 (B) a pharmacy, hospital, or other institution licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to, or to administer a controlled substance in the course of professional practice or research in the state;
 (21) “recreation or youth center” means a building, structure, athletic playing field, or playground
            (A) run or created by a municipality or the state to provide athletic, recreational, or leisure activities for minors; or
 (B) operated by a public or private organization licensed to provide shelter, training, or guidance for minors;
 (22) "sale" means to sell, barter, exchange, give, or dispose of to another, or an exchange for a thing of value;
 (23) “schedule IA controlled substance” means a controlled substance included in the schedule in
AS 11.71.140
;
 (24) “schedule IIA controlled substance” means a controlled substance included in the schedule in
AS 11.71.150
;
 (25) "schedule IIIA controlled substance" means a controlled substance included in the schedule in
AS 11.71.160
;
 (26) “schedule IVA controlled substance” means a controlled substance included in the schedule in
AS 11.71.170
;
 (27) "schedule VA controlled substance" means a controlled substance included in the schedule in
AS 11.71.180
;
 (28) “schedule VIA controlled substance” means a controlled substance included in the schedule in
AS 11.71.190
;
 (29) “school bus” means a motor vehicle operated by a school district or private school, directly or by contract, to transport students;
 (30) "school grounds" means a building, structure, athletic playing field, playground, parking area, or land contained within the real property boundary line of a public or private preschool, elementary, or secondary school;
 (31) “substance” means a drug, controlled substance, or immediate precursor included in the schedules set out in
AS 11.71.140
 — 11.71.190 or in an emergency regulation adopted under
AS 11.71.125
,
AS 44.62.250
, and 44.62.260;
 (32) "ultimate user" means a person who lawfully possesses a controlled substance for the person’s own use or for the use of a member of the person’s household or for administering to an animal owned by the person or by a member of the person’s household.

Instrument

Schedule IIA, hallucinogenic substances

Source

https://www.akleg.gov/basis/statutes.asp?media=print&secStart=11.71.140&secEnd=11.71.900

Retrieved

2026-10-31

Fingerprint

d34db23ae49d7097

(b) Schedule IIA includes, unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, whether optical, position, or geometric, or salts of isomers whenever the existence of these salts, isomers, or salts of isomers is possible within the specific chemical designation:
       (1) 4-bromo-2, 5-dimethoxy-amphetamine, also known as 4-bromo-2, 5-dimethoxy-a-methylphenethylamine and 4-bromo-2, DMA;
 (2) 2,5-dimethoxyamphetamine, also known as 2,5-dimethoxy-a-methylphenethylamine and 2,5-DMA;
 (3) 4-methoxyamphetamine, also known as 4-methoxy-a-methylphenethylamine and paramethoxyamphetamine, PMA;
 (4) 5-methoxy-3,4-methylenedioxy-amphetamine;
 (5) 4-methyl-2,5-dimethoxy-amphetamine, also known as 4-methyl-2,5-dimethoxy-a-methylphenethylamine;
 (6) 3,4-methylenedioxy amphetamine;
 (7) 3,4,5-trimethoxy amphetamine;
 (8) bufotenine, also known as 3-(B-dimethylaminoethyl)-5-hydroxyindole, 3-(2-dimethylaminoethyl)-5-indolol, N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine, and mappine;
 (9) diethyltryptamine, also known as N, N-diethyltryptamine and DET;
 (10) dimethyltryptamine, also known as DMT;
 (11) ibogaine, also known as 7-ethyl-6, 6B, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido [1�,2�: 1, 2] azepino [5, 4-b] indole and tabernanthe iboga;
 (12) lysergic acid diethylamide, also known as LSD;
 (13) mescaline;
 (14) n-ethyl-3-piperidyl benzilate;
 (15) n-methyl-3-piperidyl benzilate;
 (16) peyote;
 (17) analogs of phencyclidine (PCP), including:
            (A) ethylamine analog, also known by some trade or other names as follows: N-ethyl-1-phenylcyclohexylamine (1-phenylcyclohexyl)-ethylamine, N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
 (B) pyrrolidine analog, also known by some trade or other names as follows: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPY, PHP;
 (C) thiophene analog, also known as 1-[1-(2-thienyl) cyclohexyl]piperidine and 2-thienylanalog of phencyclidine, TPCP, and TCP;
 (D) 1-[1-(2-thienyl)-cyclohexyl]-pyrrolidine, also known as TCPy;
 (18) psilocybin;
 (19) psilocyn;
 (20) 3,4-methylenedioxymethamphetamine (MDMA).